Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma is a research paper published in Frontiers in Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R00CA263016, P30CA093373
Hartwell Foundation
Grant: A24-2412
NCI NIH HHS
Grant: P30 CA093373
NCI NIH HHS
Grant: R00 CA263016
FWCI
5.01
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals